Mechanism Action of Caboxen 20 (Cabozantinib 20 mg) Tablet
Cabozantinib is a multi-target Tyrosine Kinase Inhibitor (TKI) that blocks cancer-promoting pathways involved in tumor growth, angiogenesis, and metastasis, including VEGFR, MET, and AXL receptors.
🩺 Indications / Therapeutic Uses
Used in the treatment of:
-
Renal Cell Carcinoma (Kidney Cancer)
-
Hepatocellular Carcinoma (Liver Cancer)
-
Differentiated Thyroid Cancer (advanced or metastatic)
(As prescribed by an oncologist and according to country-specific guidelines.)
💊 Dosage & Administration
-
Dosage determined by a qualified oncologist
-
Typically taken once daily
-
Administered on an empty stomach
-
Tablets should be swallowed whole
⚠️ Safety & Precautions
-
Not recommended during pregnancy or breastfeeding
-
Regular monitoring of liver function and blood pressure required
-
Avoid grapefruit and grapefruit juice
-
Use under strict medical supervision
🌐 International Compliance Notes
-
Prescription-only oncology medicine
-
Export subject to destination country regulations
-
Product labeling and documentation available as per regulatory requirements
-
Suitable for regulated and semi-regulated markets
🧠 FAQ
Is Caboxen 20 chemotherapy?
No, it is a targeted therapy (TKI), not traditional chemotherapy.
Can Caboxen 20 be taken long-term?
Yes, if tolerated and prescribed by an oncologist.
Caboxen 20 contains Cabozantinib 20 mg, a targeted oncology therapy used in kidney, liver, and thyroid cancers. Manufactured in Bangladesh by Everest Pharmaceuticals and supplied in 90-tablet packs for international markets.
-
Cabozantinib 20 mg tablet
-
Caboxen 20 export
-
Cabozantinib oncology medicine
-
Tyrosine kinase inhibitor cancer drug
-
Anti-cancer tablets from Bangladesh
-
Cabozantinib international supplier
